Antimicrobial Effects of Minocycline, Tigecycline, Ciprofloxacin, and Levofloxacin against <i>Elizabethkingia anophelis </i>using In Vitro Time-Kill Assays and In Vivo Zebrafish Animal Models

<i>Elizabethkingia anophelis</i> is a multidrug-resistant pathogen. This study evaluated the antimicrobial activity of minocycline, tigecycline, ciprofloxacin, and levofloxacin using in vitro time-kill assays and in vivo zebrafish animal models. The <i>E. anophelis</i> strain...

Full description

Bibliographic Details
Main Authors: Jiun-Nong Lin, Chung-Hsu Lai, Yi-Han Huang, Chih-Hui Yang
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/10/3/285
id doaj-1c5786f8355f49548939812568fa65f1
record_format Article
spelling doaj-1c5786f8355f49548939812568fa65f12021-03-11T00:00:54ZengMDPI AGAntibiotics2079-63822021-03-011028528510.3390/antibiotics10030285Antimicrobial Effects of Minocycline, Tigecycline, Ciprofloxacin, and Levofloxacin against <i>Elizabethkingia anophelis </i>using In Vitro Time-Kill Assays and In Vivo Zebrafish Animal ModelsJiun-Nong Lin0Chung-Hsu Lai1Yi-Han Huang2Chih-Hui Yang3Department of Critical Care Medicine, E-Da Hospital, I-Shou University, Kaohsiung 824, TaiwanDivision of Infectious Diseases, Department of Internal Medicine, E-Da Hospital, I-Shou University, Kaohsiung 824, TaiwanSchool of Medicine, College of Medicine, I-Shou University, Kaohsiung 824, TaiwanDepartment of Biological Science and Technology, Meiho University, Pingtung 912, Taiwan<i>Elizabethkingia anophelis</i> is a multidrug-resistant pathogen. This study evaluated the antimicrobial activity of minocycline, tigecycline, ciprofloxacin, and levofloxacin using in vitro time-kill assays and in vivo zebrafish animal models. The <i>E. anophelis</i> strain <i>ED853-49</i> was arbitrarily selected from a bacterial collection which was concomitantly susceptible to minocycline, tigecycline, ciprofloxacin, and levofloxacin. The antibacterial activities of single agents at 0.5–4 × minimum inhibitory concentration (MIC) and dual-agent combinations at 2 × MIC using time-kill assays were investigated. The therapeutic effects of antibiotics in<i> E. anophelis</i>-infected zebrafish were examined. Both minocycline and tigecycline demonstrated bacteriostatic effects but no bactericidal effect. Minocycline at concentrations ≥2 × MIC and tigecycline at concentrations ≥3 × MIC exhibited a long-standing inhibitory effect for 48 h. Bactericidal effects were observed at <i>ciprofloxacin and levofloxacin concentrations of ≥</i>3 × <i>MIC</i> within 24 h of initial inoculation. Rapid <i>regrowth of E. anophelis </i>occurred <i>after </i>the initial killing phase when ciprofloxacin was used<i>, regardless of the concentration. </i>Levofloxacin treatment at the concentration of ≥2 × MIC consistently resulted in the long-lasting and sustainable inhibition of bacterial growth for 48 h. The addition of minocycline or tigecycline weakened the killing effect of fluoroquinolones during the first 10 h. The minocycline-ciprofloxacin or minocycline–levofloxacin combinations achieved the lowest colony-forming unit counts at 48 h. Zebrafish treated with minocycline or a combination of minocycline and levofloxacin had the highest survival rate (70%). The results of these in vitro and in vivo studies suggest that the combination of minocycline and levofloxacin is the most effective therapy approach for <i>E. anophelis</i> infection.https://www.mdpi.com/2079-6382/10/3/285<i>Elizabethkingia anophelis</i>minocyclinetigecyclineciprofloxacinlevofloxacinzebrafish
collection DOAJ
language English
format Article
sources DOAJ
author Jiun-Nong Lin
Chung-Hsu Lai
Yi-Han Huang
Chih-Hui Yang
spellingShingle Jiun-Nong Lin
Chung-Hsu Lai
Yi-Han Huang
Chih-Hui Yang
Antimicrobial Effects of Minocycline, Tigecycline, Ciprofloxacin, and Levofloxacin against <i>Elizabethkingia anophelis </i>using In Vitro Time-Kill Assays and In Vivo Zebrafish Animal Models
Antibiotics
<i>Elizabethkingia anophelis</i>
minocycline
tigecycline
ciprofloxacin
levofloxacin
zebrafish
author_facet Jiun-Nong Lin
Chung-Hsu Lai
Yi-Han Huang
Chih-Hui Yang
author_sort Jiun-Nong Lin
title Antimicrobial Effects of Minocycline, Tigecycline, Ciprofloxacin, and Levofloxacin against <i>Elizabethkingia anophelis </i>using In Vitro Time-Kill Assays and In Vivo Zebrafish Animal Models
title_short Antimicrobial Effects of Minocycline, Tigecycline, Ciprofloxacin, and Levofloxacin against <i>Elizabethkingia anophelis </i>using In Vitro Time-Kill Assays and In Vivo Zebrafish Animal Models
title_full Antimicrobial Effects of Minocycline, Tigecycline, Ciprofloxacin, and Levofloxacin against <i>Elizabethkingia anophelis </i>using In Vitro Time-Kill Assays and In Vivo Zebrafish Animal Models
title_fullStr Antimicrobial Effects of Minocycline, Tigecycline, Ciprofloxacin, and Levofloxacin against <i>Elizabethkingia anophelis </i>using In Vitro Time-Kill Assays and In Vivo Zebrafish Animal Models
title_full_unstemmed Antimicrobial Effects of Minocycline, Tigecycline, Ciprofloxacin, and Levofloxacin against <i>Elizabethkingia anophelis </i>using In Vitro Time-Kill Assays and In Vivo Zebrafish Animal Models
title_sort antimicrobial effects of minocycline, tigecycline, ciprofloxacin, and levofloxacin against <i>elizabethkingia anophelis </i>using in vitro time-kill assays and in vivo zebrafish animal models
publisher MDPI AG
series Antibiotics
issn 2079-6382
publishDate 2021-03-01
description <i>Elizabethkingia anophelis</i> is a multidrug-resistant pathogen. This study evaluated the antimicrobial activity of minocycline, tigecycline, ciprofloxacin, and levofloxacin using in vitro time-kill assays and in vivo zebrafish animal models. The <i>E. anophelis</i> strain <i>ED853-49</i> was arbitrarily selected from a bacterial collection which was concomitantly susceptible to minocycline, tigecycline, ciprofloxacin, and levofloxacin. The antibacterial activities of single agents at 0.5–4 × minimum inhibitory concentration (MIC) and dual-agent combinations at 2 × MIC using time-kill assays were investigated. The therapeutic effects of antibiotics in<i> E. anophelis</i>-infected zebrafish were examined. Both minocycline and tigecycline demonstrated bacteriostatic effects but no bactericidal effect. Minocycline at concentrations ≥2 × MIC and tigecycline at concentrations ≥3 × MIC exhibited a long-standing inhibitory effect for 48 h. Bactericidal effects were observed at <i>ciprofloxacin and levofloxacin concentrations of ≥</i>3 × <i>MIC</i> within 24 h of initial inoculation. Rapid <i>regrowth of E. anophelis </i>occurred <i>after </i>the initial killing phase when ciprofloxacin was used<i>, regardless of the concentration. </i>Levofloxacin treatment at the concentration of ≥2 × MIC consistently resulted in the long-lasting and sustainable inhibition of bacterial growth for 48 h. The addition of minocycline or tigecycline weakened the killing effect of fluoroquinolones during the first 10 h. The minocycline-ciprofloxacin or minocycline–levofloxacin combinations achieved the lowest colony-forming unit counts at 48 h. Zebrafish treated with minocycline or a combination of minocycline and levofloxacin had the highest survival rate (70%). The results of these in vitro and in vivo studies suggest that the combination of minocycline and levofloxacin is the most effective therapy approach for <i>E. anophelis</i> infection.
topic <i>Elizabethkingia anophelis</i>
minocycline
tigecycline
ciprofloxacin
levofloxacin
zebrafish
url https://www.mdpi.com/2079-6382/10/3/285
work_keys_str_mv AT jiunnonglin antimicrobialeffectsofminocyclinetigecyclineciprofloxacinandlevofloxacinagainstielizabethkingiaanophelisiusinginvitrotimekillassaysandinvivozebrafishanimalmodels
AT chunghsulai antimicrobialeffectsofminocyclinetigecyclineciprofloxacinandlevofloxacinagainstielizabethkingiaanophelisiusinginvitrotimekillassaysandinvivozebrafishanimalmodels
AT yihanhuang antimicrobialeffectsofminocyclinetigecyclineciprofloxacinandlevofloxacinagainstielizabethkingiaanophelisiusinginvitrotimekillassaysandinvivozebrafishanimalmodels
AT chihhuiyang antimicrobialeffectsofminocyclinetigecyclineciprofloxacinandlevofloxacinagainstielizabethkingiaanophelisiusinginvitrotimekillassaysandinvivozebrafishanimalmodels
_version_ 1724226310450970624